Expanding Global Access to Innovative Medical Therapies

Investments in pharma and biotech have advanced innovative therapies like gene and cell-based treatments, offering new hope for severe diseases. However, access remains limited, especially in low- and middle-income countries, due to eligibility, geographical barriers, and high costs. This session’s panel of experts will discuss the urgent need for collaborative efforts to ensure fair and sustainable global access to these transformative therapies.